This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bhujwalla, Z. M. Articles by Kristjansen, P. E. G. Search for Related Content PubMed PubMed Citation Articles by Bhujwalla, Z. M. Articles by Kristjansen, P. E. G.

Reduction of Vascular and Permeable Regions in Solid Tumors Detected by Macromolecular Contrast Magnetic Resonance Imaging after Treatment with Antiangiogenic Agent TNP-470¹

Magnetic Resonance Oncology Section, Division of Magnetic Resonance Research, Department of Radiology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 [Z. M. B., D. A., K. N., M. S., P. K.], and Institute of Molecular Pathology, University of Copenhagen, DK-2100 Copenhagen, Denmark [P. E. G. K.]

Purpose: The availability of noninvasive techniques to detect the effects of antiangiogenic agents is critically important for optimizing treatment of cancer with these agents. Magnetic resonance imaging (MRI) is one such noninvasive technique that is routinely used clinically.

Experimental Design: In this study, we have evaluated the use of MRI of the intravascular contrast agent albumin-GdDTPA to detect the effects of the antiangiogenic agent TNP-470 on the vascular volume and permeability of the MatLyLu prostate cancer model.

Results: TNP-470-treated tumors demonstrated a significant decrease of vascular volume, as well as a significant reduction in vascular and permeable regions, compared with volume-matched control tumors. Although the fractional volume of permeable regions in the tumor decreased, the average value of tumor permeability did not decrease significantly. This was attributable to increase in permeability in some regions of the tumor. These regions were mostly associated with low vascular volume. ELISA assays of control and treated MatLyLu tumors also detected a significant increase of vascular endothelial growth factor in the TNP-470-treated tumors.

Conclusion: MRI detected significant changes in tumor vascular characteristics after treatment with TNP-470.

This article has been cited by other articles:

				R. Jain, S.K. Ellika, L. Scarpace, L.R. Schultz, J.P. Rock, J. Gutierrez, S.C. Patel, J. Ewing, and T. Mikkelsen Quantitative Estimation of Permeability Surface-Area Product in Astroglial Brain Tumors Using Perfusion CT and Correlation with Histopathologic Grade AJNR Am. J. Neuroradiol., April 1, 2008; 29(4): 694 - 700. [Abstract] [Full Text] [PDF]

				C. Li, M.-F. Penet, P. Winnard Jr., D. Artemov, and Z. M. Bhujwalla Image-Guided Enzyme/Prodrug Cancer Therapy Clin. Cancer Res., January 15, 2008; 14(2): 515 - 522. [Abstract] [Full Text] [PDF]

				H.S. Kim and S.Y. Kim A Prospective Study on the Added Value of Pulsed Arterial Spin-Labeling and Apparent Diffusion Coefficients in the Grading of Gliomas AJNR Am. J. Neuroradiol., October 1, 2007; 28(9): 1693 - 1699. [Abstract] [Full Text] [PDF]

				D. Nahari, R. Satchi-Fainaro, M. Chen, I. Mitchell, L. B. Task, Z. Liu, J. Kihneman, A. B. Carroll, L. S. Terada, and F. E. Nwariaku Tumor cytotoxicity and endothelial Rac inhibition induced by TNP-470 in anaplastic thyroid cancer Mol. Cancer Ther., April 1, 2007; 6(4): 1329 - 1337. [Abstract] [Full Text] [PDF]

				Y. Mironchik, P. T. Winnard Jr., F. Vesuna, Y. Kato, F. Wildes, A. P. Pathak, S. Kominsky, D. Artemov, Z. Bhujwalla, P. Van Diest, et al. Twist Overexpression Induces In vivo Angiogenesis and Correlates with Chromosomal Instability in Breast Cancer Cancer Res., December 1, 2005; 65(23): 10801 - 10809. [Abstract] [Full Text] [PDF]

				Y. R. Kim, A. Yudina, J. Figueiredo, W. Reichardt, D. Hu-Lowe, A. Petrovsky, H. W. Kang, D. Torres, U. Mahmood, R. Weissleder, et al. Detection of Early Antiangiogenic Effects in Human Colon Adenocarcinoma Xenografts: In vivo Changes of Tumor Blood Volume in Response to Experimental VEGFR Tyrosine Kinase Inhibitor Cancer Res., October 15, 2005; 65(20): 9253 - 9260. [Abstract] [Full Text] [PDF]

				P. Marzola, A. Degrassi, L. Calderan, P. Farace, E. Nicolato, C. Crescimanno, M. Sandri, A. Giusti, E. Pesenti, A. Terron, et al. Early Antiangiogenic Activity of SU11248 Evaluated In vivo by Dynamic Contrast-Enhanced Magnetic Resonance Imaging in an Experimental Model of Colon Carcinoma Clin. Cancer Res., August 15, 2005; 11(16): 5827 - 5832. [Abstract] [Full Text] [PDF]

				N.-M. Tsai, S.-Z. Lin, C.-C. Lee, S.-P. Chen, H.-C. Su, W.-L. Chang, and H.-J. Harn The Antitumor Effects of Angelica sinensis on Malignant Brain Tumors In vitro and In vivo Clin. Cancer Res., May 1, 2005; 11(9): 3475 - 3484. [Abstract] [Full Text] [PDF]

				Q. G. de Lussanet, S. Langereis, R. G. H. Beets-Tan, M. H. P. van Genderen, A. W. Griffioen, J. M. A. van Engelshoven, and W. H. Backes Dynamic Contrast-enhanced MR Imaging Kinetic Parameters and Molecular Weight of Dendritic Contrast Agents in Tumor Angiogenesis in Mice Radiology, April 1, 2005; 235(1): 65 - 72. [Abstract] [Full Text] [PDF]

				J. C. Miller, H. H. Pien, D. Sahani, A. G. Sorensen, and J. H. Thrall Imaging Angiogenesis: Applications and Potential for Drug Development J Natl Cancer Inst, February 2, 2005; 97(3): 172 - 187. [Abstract] [Full Text] [PDF]

				B. F. Jordan, M. Runquist, N. Raghunand, R. J. Gillies, W. R. Tate, G. Powis, and A. F. Baker The Thioredoxin-1 Inhibitor 1-Methylpropyl 2-Imidazolyl Disulfide (PX-12) Decreases Vascular Permeability in Tumor Xenografts Monitored by Dynamic Contrast Enhanced Magnetic Resonance Imaging Clin. Cancer Res., January 15, 2005; 11(2): 529 - 536. [Abstract] [Full Text] [PDF]

				M. Cristofanilli and G. N. Hortobagyi Breast Cancer Highlights: Key Findings from the San Antonio Breast Cancer Symposium: A U.S. Perspective Oncologist, July 1, 2004; 9(4): 471 - 478. [Abstract] [Full Text] [PDF]

				M. Law, K. Kazmi, S. Wetzel, E. Wang, C. Iacob, D. Zagzag, J. G. Golfinos, and G. Johnson Dynamic Susceptibility Contrast-Enhanced Perfusion and Conventional MR Imaging Findings for Adult Patients with Cerebral Primitive Neuroectodermal Tumors AJNR Am. J. Neuroradiol., June 1, 2004; 25(6): 997 - 1005. [Abstract] [Full Text] [PDF]

				M. Law, S. Yang, J. S. Babb, E. A. Knopp, J. G. Golfinos, D. Zagzag, and G. Johnson Comparison of Cerebral Blood Volume and Vascular Permeability from Dynamic Susceptibility Contrast-Enhanced Perfusion MR Imaging with Glioma Grade AJNR Am. J. Neuroradiol., May 1, 2004; 25(5): 746 - 755. [Abstract] [Full Text] [PDF]

				P. Marzola, A. Degrassi, L. Calderan, P. Farace, C. Crescimanno, E. Nicolato, A. Giusti, E. Pesenti, A. Terron, A. Sbarbati, et al. In Vivo Assessment of Antiangiogenic Activity of SU6668 in an Experimental Colon Carcinoma Model Clin. Cancer Res., January 15, 2004; 10(2): 739 - 750. [Abstract] [Full Text] [PDF]